SARAH Exercise Program in Patients With Rheumatoid Arthritis
Launched by IZMIR KATIP CELEBI UNIVERSITY · Feb 4, 2023
Trial Information
Current as of June 09, 2025
Completed
Keywords
ClinConnect Summary
Finger/hand/wrist joints can be affected in the early period in patients with RA, and as the disease progresses, it can significantly limit the patient's functionality. Damage to articular and periarticular structures seen in inflammatory arthritis may affect the sense of proprioception by destroying mechanoreceptors located in these areas. Hand functions may worsen as a result of the worsening of the sense of proprioception, which can be defined as being aware of body parts.
SARAH (Strengthening and Stretching for Rheumatoid Arthritis of the Hand) home exercise program, which is a widely ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. RA diagnosis according to 2010 ACR/EULAR RA criteria
- • 2. Being between the ages of 18-65
- • 3. Being able to follow Turkish instructions
- • 4. Volunteering to participate in the study
- Exclusion Criteria:
- • 1. Being in an acute disease exacerbation period
- • 2. Ongoing physiotherapy/occupational/exercise treatment regarding hands within the last 6 months
- • 3. History of steroid injection, surgery, or trauma to the upper extremity in the last 6 months
About Izmir Katip Celebi University
Izmir Katip Celebi University is a prominent academic institution in Turkey, dedicated to advancing medical research and education. The university is committed to fostering innovation and excellence in clinical trials, leveraging its state-of-the-art facilities and a multidisciplinary team of experienced researchers and healthcare professionals. With a focus on improving patient outcomes and contributing to the global body of medical knowledge, Izmir Katip Celebi University actively engages in collaborative research initiatives, aiming to address critical health challenges through rigorous scientific inquiry and ethical practices in clinical trial management.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
İzmir, , Turkey
Patients applied
Trial Officials
Deniz Bayraktar, PT, PhD
Principal Investigator
Izmir Katip Celebi University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials